本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Mereo Biopharma Group Plc

2.31
+0.310015.50%
成交量:308.31萬
成交額:688.47萬
市值:3.68億
市盈率:-8.79
高:2.36
開:2.09
低:2.07
收:2.00
52周最高:3.88
52周最低:1.47
股本:1.59億
流通股本:1.00億
量比:1.84
換手率:3.07%
股息:- -
股息率:- -
每股收益(TTM):-0.2629
每股收益(LYR):-0.2924
淨資產收益率:-69.79%
總資產收益率:-39.81%
市淨率:7.89
市盈率(LYR):-7.90

資料載入中...

2020/02/18

員工持股計劃

Securities to be offered to employees in employee benefit plans
2020/02/18

招股説明書

Registration statement for certain foreign private issuers
2020/02/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/22

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/17

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/24

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/16

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/15

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/20

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/29

[修訂]年度報告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]